NCT05647070 Long-term Outcomes of Autologous Transobturator Rectus Fascia Sling for Treatment of Female Stress Urinary Incontinence
| NCT ID | NCT05647070 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Azhar University |
| Condition | Stress Urinary Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-12-01 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autologous transobturator sling placement is associated with excellent short-term results and can be performed on an outpatient basis in most cases, so long-term outcomes needs to be verified.
Eligibility Criteria
Inclusion Criteria: * Women with genuine stress urinary incontinence. * Mixed urinary incontinence with predominant stress element. * Refractory cases to conservative therapy or patients who are not willing to consider (further) conservative treatment. Exclusion Criteria: * Mild Stress urinary incontinence with improvement on conservative therapy or patients refusing surgical treatment. * Mixed incontinence with predominant Urge urinary incontinence. * Associated local abnormalities (e.g. cystocele). * Recent or active urinary tract infection. * Recent pelvic surgery. * Neurogenic lower urinary tract dysfunction. * Previous surgery for stress urinary incontinence. * Pregnancy * Less than 12 months post-partum. * Other gynaecologic pathologies affecting bladder functions ( eg,large fibroids) * Genito-urinary malignancy. * Current chemo or radiation therapy.
Frequently Asked Questions
Who can join the NCT05647070 clinical trial?
This trial is open to female participants only, studying Stress Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05647070 currently recruiting?
Yes, NCT05647070 is actively recruiting participants. Visit ClinicalTrials.gov or contact Al-Azhar University to inquire about joining.
Where is the NCT05647070 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT05647070 clinical trial?
NCT05647070 is sponsored by Al-Azhar University. The trial plans to enroll 200 participants.